Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2022-01-18 00:00:00 ET · period of report 2022-01-14 · accession 0001453687-22-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-18 | 2022-01-14 | RNAC | BARABE TIMOTHY C | Dir | M - OptEx | $2.10 | +10.0K | 200.0K | +5% | +$21.0K |
| D | 2022-01-18 | 2022-01-14 | RNAC | BARABE TIMOTHY C | Dir | M - OptEx | $2.10 | -10.0K | 0 | -100% | -$21.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-14 | M | A | 10,000 | $2.10 | 200,013 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-14 | M | D | 10,000 | $2.10 | 0 | D | $2.10 · — to 2029-06-13 | 10,000 Common Stock | (F1) This option is fully vested. |